Stephanie Keener
Payments from drug & device makers
Across 120 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$692
- Otsuka America Pharmaceutical, Inc.$552
- AstraZeneca$266
- Amarin Pharma, Inc.$131
- Alkermes, Inc.$109
- Johnson & Johnson$49
- plus $301 from 11 others
What the payments were for
- Food & beverage$2,100100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $692 |
| Otsuka America Pharmaceutical, Inc. | 29 | $552 |
| AstraZeneca | 7 | $266 |
| Amarin Pharma, Inc. | 10 | $131 |
| Alkermes, Inc. | 4 | $109 |
| Johnson & Johnson | 2 | $49 |
| Merck | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 3 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Indivior Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Gilead | 1 | $15 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$125
- Mavyret$124
- BREZTRI$103
How this compares
$2,100 in reported general payments places this provider in the 75th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 40 | $3,066 |
| Gabapentin | 13 | $143 |
| Trazodone Hcl | 13 | $77 |
| Quetiapine Fumarate | 15 | $47 |
Paid to pharmacies, not to this prescriber.
Other medical in Xenia
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
- Melanie HunglerCincinnati$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.